ZA200509079B - Novel 14 and 15 membered-ring compounds - Google Patents

Novel 14 and 15 membered-ring compounds

Info

Publication number
ZA200509079B
ZA200509079B ZA200509079A ZA200509079A ZA200509079B ZA 200509079 B ZA200509079 B ZA 200509079B ZA 200509079 A ZA200509079 A ZA 200509079A ZA 200509079 A ZA200509079 A ZA 200509079A ZA 200509079 B ZA200509079 B ZA 200509079B
Authority
ZA
South Africa
Prior art keywords
membered
novel
ring compounds
compounds
ring
Prior art date
Application number
ZA200509079A
Other languages
English (en)
Inventor
Alihodzic Sulejman
Jarvest Richard Lewis
Pavlovic Drazen
Forrest Andrew Keith
Lazarevski Gorjana
Original Assignee
Glaxo Group Ltd
Pliva Istrazivacki Inst D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Istrazivacki Inst D O O filed Critical Glaxo Group Ltd
Publication of ZA200509079B publication Critical patent/ZA200509079B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200509079A 2003-05-13 2005-11-09 Novel 14 and 15 membered-ring compounds ZA200509079B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0310986.5A GB0310986D0 (en) 2003-05-13 2003-05-13 Novel compounds

Publications (1)

Publication Number Publication Date
ZA200509079B true ZA200509079B (en) 2007-02-28

Family

ID=9957984

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200509079A ZA200509079B (en) 2003-05-13 2005-11-09 Novel 14 and 15 membered-ring compounds

Country Status (22)

Country Link
US (1) US7569550B2 (enExample)
EP (1) EP1628988B1 (enExample)
JP (1) JP2007502313A (enExample)
KR (1) KR20060026407A (enExample)
CN (1) CN1849328A (enExample)
AR (1) AR044309A1 (enExample)
AT (1) ATE341560T1 (enExample)
AU (1) AU2004238528A1 (enExample)
BR (1) BRPI0410246A (enExample)
CA (1) CA2525452A1 (enExample)
CL (1) CL2004001010A1 (enExample)
DE (1) DE602004002696T2 (enExample)
DK (1) DK1628988T3 (enExample)
ES (1) ES2273255T3 (enExample)
GB (1) GB0310986D0 (enExample)
HR (1) HRP20060448T3 (enExample)
MX (1) MXPA05012163A (enExample)
PL (1) PL1628988T3 (enExample)
PT (1) PT1628988E (enExample)
RU (1) RU2005134908A (enExample)
WO (1) WO2004101586A1 (enExample)
ZA (1) ZA200509079B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
EP1851236B1 (en) * 2005-01-13 2010-08-04 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Macrolides with anti-inflammatory activity
WO2006120541A1 (en) * 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections
PE20070802A1 (es) * 2005-11-09 2007-10-19 Glaxo Group Ltd Derivados de eritromicina 4''-sustituidos como agentes antimicrobianos
EP1945652A1 (en) * 2005-11-09 2008-07-23 Glaxo Group Limited Macrolones
EP2384333B1 (en) 2009-01-30 2013-04-17 Glaxo Group Limited Anti-inflammatory macrolide
CN111574575B (zh) * 2020-04-29 2022-05-17 北京理工大学 一种含有大环内酯基的喹喏酮衍生物、制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE128714T1 (de) * 1989-03-28 1995-10-15 Abbott Lab Erythromycinderivate.
WO1996034007A1 (es) * 1995-04-27 1996-10-31 Laboratorios Aranda, S.A. De C.V. Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen
CA2253451A1 (en) * 1996-05-07 1997-11-13 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
WO2003014136A1 (en) * 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
US20070185117A1 (en) 2007-08-09
ATE341560T1 (de) 2006-10-15
AR044309A1 (es) 2005-09-07
CA2525452A1 (en) 2004-11-25
HRP20060448T3 (hr) 2007-03-31
GB0310986D0 (en) 2003-06-18
EP1628988A1 (en) 2006-03-01
MXPA05012163A (es) 2006-05-19
CL2004001010A1 (es) 2005-03-18
CN1849328A (zh) 2006-10-18
RU2005134908A (ru) 2006-06-27
DE602004002696T2 (de) 2007-08-16
PL1628988T3 (pl) 2007-03-30
ES2273255T3 (es) 2007-05-01
AU2004238528A1 (en) 2004-11-25
DK1628988T3 (da) 2007-02-05
DE602004002696D1 (de) 2006-11-16
WO2004101586A1 (en) 2004-11-25
EP1628988B1 (en) 2006-10-04
KR20060026407A (ko) 2006-03-23
BRPI0410246A (pt) 2006-05-16
JP2007502313A (ja) 2007-02-08
US7569550B2 (en) 2009-08-04
PT1628988E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
GB0309138D0 (en) Design 2
GB0229742D0 (en) Novel compounds and uses thereof
EP1617807A4 (en) SUBSTITUTED 1,4-DIAZEPINE AND ITS USES
PL1628989T3 (pl) Nowe związki o 14- i 15- członowym pierścieniu
DE502004012210D1 (en) Ment yellow 74
GB0220501D0 (en) Push 22
ZA200509079B (en) Novel 14 and 15 membered-ring compounds
SI1628988T1 (sl) Nove 14- in 15-clenske obrocne spojine
GB0313308D0 (en) Design 1
GB0206835D0 (en) Iv 2
GB2406658B (en) Novel 360 camera
GB0329755D0 (en) Doormate 2000
GB0222015D0 (en) Means of assembly-bozz 2
GB2425310B (en) N-aryloxypropanolyl-N' -phenethyl-urea
GB0209835D0 (en) Easy 1
GB0203312D0 (en) 8323610001
GB0205625D0 (en) Lazline 3000
GB0323939D0 (en) Art 7
GB0322097D0 (en) Carry 3
GB0318769D0 (en) Improved 'smpsogi'
GB0327449D0 (en) 100 1st
GB0314147D0 (en) Design 1
GB0219989D0 (en) Carry 3
GB0222241D0 (en) TSPGolf - putter#001
GB0425567D0 (en) Productive zeroclick 7